Furthermore, PRMT1 facilitates epithelial–mesenchymal transition (EMT) via the upregulation of pathways such as ZEB1 and TGF‐β/Smad, promotes tumor angiogenesis by regulating vascular endothelial growth factor (VEGF), and contributes to chemotherapy resistance by modifying metabolic enzymes and DNA repair proteins. This evidence concerns the gene PRMT1 and neoplasm.